Stool DNA Analysis Cost-effective Check for Colon Cancer in Ulcerative Colitis Patients

Stool DNA Analysis Cost-effective Check for Colon Cancer in Ulcerative Colitis Patients
A recent study indicated that while colorectal cancer (CRC) surveillance in patients with ulcerative colitis was generally cost effective, the addition of stool DNA analysis to surveillance colonoscopy was the most cost-effective approach. If a stool DNA test is positive, then a colonoscopy would be performed, the researchers said. The study, “
Subscribe or to access all post and page content.